Skip To Main Content
Orna T. Cantillon on Muck Rack

Orna T. Cantillon

As seen in: Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Orna T.

Contact Orna T., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Neoadjuvant Immune Therapy in Patients With Melanoma: Response and Toxicity in a Non-Clinical Trial Setting

|
By Klaus J. Busam, Charlotte E. Ariyan, Orna T. Cantillon
| Wiley Online Library Verified
Data Availability Statement The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. References 1, , and , “ Malignant Melanoma,” in StatPearls [Internet]. StatPearls Publishing, 2024, http://www.ncbi.nlm.nih.gov/books/NBK470409/. 2, , , et al., “Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma,” New England Journal of Medicine 391, no.
Open in Who Shared Issue with article?
See all 1 articles